← Back to Search

Integrated Strategy for PrEP Uptake in HIV Prevention

N/A

Waitlist Available

Research Sponsored by HIV Prevention Trials Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-report a lifetime history of sex with other men

Are at least 15 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured with data available at the end of the three year intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial is designed to see if an integrated strategy approach can increase uptake and use of pre-exposure prophylaxis (PrEP) and viral suppression rates among Black MSM in the southern United States.

Who is the study for?

This trial is for Black men, including cisgender and transgender, who have had sexual relations with other men. Participants must be at least 15 years old, live in the study area, and consent to a questionnaire and blood tests. HIV status doesn't matter for joining.

What is being tested?

The study is testing an approach that combines health equity efforts, stigma reduction strategies, standard care enhancements, social media influencer involvement, and peer support to improve PrEP use and viral suppression among Black MSM in the South.

What are the potential side effects?

Since this trial focuses on community-based interventions rather than medications or medical procedures directly administered to participants, specific side effects are not anticipated as part of the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had sexual relations with other men in my lifetime.

Select...

I am 15 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured with data available at the end of the three year intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured with data available at the end of the three year intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured with data available at the end of the three year intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

PrEP use by Black MSM not living with HIV

Viral suppression in Black MSM living with diagnosed HIV

Secondary study objectives

Care quality of Black MSM needs at HCFs participating in CRISP

Compare barriers to healthcare in Black MSM in the intervention to the SOC communities

Compare individual agency in Black MSM in the intervention to the SOC communities

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard-of-careExperimental Treatment1 Intervention

Black MSM living in standard-of-care communities will have access to standard HIV prevention and care services available in their communities.

Group II: Integrated StrategyExperimental Treatment4 Interventions

Black MSM living in intervention communities will have access to the HPTN 096 integrated strategy in addition to standard HIV prevention and care services available in their communities. The integrated strategy includes a combination of four community-, organizational-, and interpersonal-level components designed to impact individual-level outcomes.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Peer Support

2011

N/A

~6500

0 / 2Eligibility criteria met